ποΈ Episode 38: TXA for ICH: Not the Magic Bullet
Manage episode 478124853 series 3659512
π§ͺ Study:
TXA within 2 hrs of ICH did not reduce hematoma expansion.
No benefit in functional outcome or mortality.
β οΈ Note:
Slight β in thromboembolic events (3% vs 1%).
π§© Clinical Takeaway:
No routine use for TXA in spontaneous ICH.
Still potential niche use in select trauma cases.
Please visit www.Brilliantcourses.com to reflect on this activity with Learner+ platform to earn CME/CE.
Chapters
1. Introduction to TXA for Brain Hemorrhage (00:00:00)
2. Clinical Trial Results Revealed (00:01:15)
3. Conclusion: TXA's Ineffectiveness (00:01:55)
45 episodes